Open AccessSingle-Dose Azithromycin for Genital Lymphogranuloma Venereum Biovar Chlamydia trachomatis Infection in HIV-Infected Women in South Africa: An Observational Study
Author(s) -
Remco P. H. Peters,
Liteboho Maduna,
Marleen M. Kock,
James McIntyre,
Jeffrey D. Klausner,
Andrew MedinaMarino
Publication year - 2020
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000001243
Subject(s) - lymphogranuloma venereum , biovar , chlamydia trachomatis , azithromycin , medicine , sex organ , men who have sex with men , chlamydia , sexually transmitted disease , virology , human immunodeficiency virus (hiv) , microbiology and biotechnology , immunology , antibiotics , biology , syphilis , bacteria , genetics
We conducted an observational study of lymphogranuloma venereum (LGV) biovar Chlamydia trachomatis infection in HIV-infected women in South Africa. The LGV biovar was detected in vaginal specimens of 17 (20%) of 85 women with C. trachomatis infection; 29% were symptomatic. All cases were negative for the LGV biovar after single-dose azithromycin.